Showing 21 - 40 results of 242 for search '"SARS"', query time: 0.09s Refine Results
  1. 21
  2. 22

    A systematic review of neurological symptoms and brain abnormalities in SARS-CoV-2 infections by Daniel Montoya, Jacobo Albert, Sarah Lopez-Martin

    Published 2023-08-01
    “…There are unknown long-term effects that may impact currently infected patients if the description of neurological symptoms and mapping of brain areas affected by SARS-CoV-2 are not accomplished.…”
    Get full text
    Article
  3. 23

    Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections by Keneth Iceland, Kasozi, Simon Peter, Musinguzi

    Published 2021
    Subjects: “…bee venom, complementary medicine and alternative medicine, SARS-CoV-2 (2019-nCoV), pharmokinetics of bee poison, COVID-19 and complementary medicine, bee venom in clinical trials…”
    Get full text
    Article
  4. 24

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Keneth Iceland, Kasozi

    Published 2021
    Subjects: “…COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola…”
    Get full text
    Article
  5. 25
  6. 26
  7. 27

    Filtration efficiency of medical and community face masks against particles carrying SARS-CoV-2 by Sara Dalvand, Rasul Nasiri, Rasoul Yarahmadi, Farah Bokharaei-Salim, Ali-Asghar Farshad, Somayeh Soleimani-Alyar

    Published 2024-12-01
    “… Introduction: Airborne bioaerosols like SARS-CoV-2 can pose a significant threat to the respiratory system of humans. …”
    Get full text
    Article
  8. 28

    Tracking the genetic diversity of SARS-CoV-2 variants in Nicaragua throughout the COVID-19 pandemic by Gerald Vásquez Alemán, Cristhiam Cerpas, Jose G. Juarez, Hanny Moreira, Sonia Arguello, Josefina Coloma, Eva Harris, Aubree Gordon, Shannon N. Bennett, Ángel Balmaseda

    Published 2025-02-01
    “…Abstract The global circulation of SARS-CoV-2 has been extensively documented; however, the dynamics within Central America, particularly Nicaragua, remain underexplored. …”
    Get full text
    Article
  9. 29
  10. 30

    Simulation-based validation of a method to detect changes in SARS-CoV-2 reinfection risk. by Belinda Lombard, Harry Moultrie, Juliet R C Pulliam, Cari van Schalkwyk

    Published 2025-02-01
    “…Given the high global seroprevalence of SARS-CoV-2, understanding the risk of reinfection has become increasingly important. …”
    Get full text
    Article
  11. 31
  12. 32

    SARS-CoV-2 Remained Airborne for a Prolonged Time in a Lockdown Confined Space by Xinyue Li, Xiao Qi, Jianxin Ma, Yang Pan, Tian Tian, Yue Zhang, Zhen Li, Wenjing Li, Lingli Sun, Lu Zhang, Zheng Zhang, Quanyi Wang, Maosheng Yao

    Published 2022-01-01
    “…Out of 25 positive environmental air and surface swab samples (N = 237) collected, SARS-CoV-2 was found to have remained airborne (5640–7840 RNA copies m−3) for more than 4 days in a female washroom. …”
    Get full text
    Article
  13. 33

    Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry. by Nousheen Bibi, Maleeha Shah, Shahzad Khan, Muhammad Shahzad Chohan, Mohammad Amjad Kamal

    Published 2025-01-01
    “…The entry and infectivity of a virus are determined by its interaction with the host. SARS-CoV-2, the virus responsible for COVID-19, utilizes the spike (S) protein to attach to and enter host cells. …”
    Get full text
    Article
  14. 34
  15. 35
  16. 36
  17. 37
  18. 38
  19. 39

    A data-driven semi-parametric model of SARS-CoV-2 transmission in the United States. by John M Drake, Andreas Handel, Éric Marty, Eamon B O'Dea, Tierney O'Sullivan, Giovanni Righi, Andrew T Tredennick

    Published 2023-11-01
    “…To support decision-making and policy for managing epidemics of emerging pathogens, we present a model for inference and scenario analysis of SARS-CoV-2 transmission in the USA. The stochastic SEIR-type model includes compartments for latent, asymptomatic, detected and undetected symptomatic individuals, and hospitalized cases, and features realistic interval distributions for presymptomatic and symptomatic periods, time varying rates of case detection, diagnosis, and mortality. …”
    Get full text
    Article
  20. 40